Gonococcal infections and emergence of gonococcal decreased susceptibility to cephalosporins in France, 2001 to 2012

Euro Surveill. 2014 Aug 28;19(34):20885. doi: 10.2807/1560-7917.es2014.19.34.20885.

Authors

G La Ruche¹, A Goubard, B Bercot, E Cambau, C Semaille, P Sednaoui

Affiliation

¹ French Institute for Public Heath Surveillance, Department of infectious diseases, Saint-Maurice, France.

PMID: 25188611
DOI: 10.2807/1560-7917.es2014.19.34.20885

No abstract available

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents / pharmacology*
Anti-Bacterial Agents / therapeutic use
Cephalosporins / pharmacology*
Cephalosporins / therapeutic use
Child
Child, Preschool
Drug Resistance, Bacterial*
Female
France / epidemiology
Gonorrhea / drug therapy*
Gonorrhea / epidemiology
Humans
Infant
Infant, Newborn
Male
Microbial Sensitivity Tests
Multivariate Analysis
Neisseria gonorrhoeae / drug effects*
Neisseria gonorrhoeae / isolation & purification
Sentinel Surveillance
Young Adult

Substances

Anti-Bacterial Agents
Cephalosporins